MN1 and astroblastoma: Notably, the 2021 WHO classification of central nervous system tumors has integrated molecular diagnostics, recognizing “astroblastoma, MN1-altered” as a distinct entity within the category of circumscribed astrocytic gliomas, characterized by the presence of meningioma 1 (MN1) gene alterations (7, 10).